New Contrast Media and Associated Injectors/Consumables framework launched

We are delighted to announce the launch of our new Contrast Media and Associated Injectors/Consumables framework. This framework plays a critical role in enabling early diagnosis and intervention, aligning with NHS ambitions to reduce diagnostic delays and improve population health outcomes. Through consolidation of regional agreements and supplier rationalisation, it enables procurement efficiencies, supports standardisation, and reduces the burden on individual NHS organisations.

This framework is delivered by the four regional NHS procurement hubs, NHS Commercial Solutions, East of England Collaborative Procurement Hub (EOE CPH), NHS North of England Commercial Procurement Collaborative, and ourselves as the lead procurement hub and Contracting Authority responsible for establishing and managing the agreement. We would like to thank all the procurement hubs involved, for their input and support in helping to deliver this framework.  

Duration

1 July 2025 – 30 June 2027 (24 months)

Benefits

• Legally compliant and transparent: procured under PCR 2015 through a fully compliant and fair process (the Procurement Act 2023 does not apply)
• High quality through regulatory assurance: suppliers meet all relevant British, EU, and MHRA standards
• Reliable supply and service: the framework prioritises consistent supply and strong customer service
• NHS-aligned: fully compliant with NHS terms and conditions
• Experienced suppliers: broad supplier coverage across all lots
• Injector support: maintenance and warranty services for injectors are included
• Innovative offers: unique supplier propositions, e.g. free loan of CT injectors for three years when consumables are purchased
• Time and cost efficient: spares NHS trusts from running their own full procurement exercises
• Flexible procurement: further competitions can be run to meet specific local needs
• Centralised contract oversight: NHS LPP and NOE CPC provide strong contract and relationship management.
• Value for money: transparent pricing, performance reviews, and benchmarking all ensure cost-effectiveness
• Risk mitigation: proactive strategies are in place to prevent disruption to supply

Awarded suppliers and lots

Lot 1 – Contrast Media Products

-Bayer Plc
-Bracco UK Ltd
-GE Healthcare
-Guerbet Lab

Lot 2 – Consumables

-Bayer Plc
-Bracco UK Ltd
-Guerbet Lab
-Leib Medical
-Uniphar MedTech

Lot 3 – Injectors

-Bayer Plc
-Bracco UK Ltd
-Guerbet Lab
-Leib Medical
-Uniphar MedTech

Sub- Lot 3A – Warranties and Maintenance
-Bracco UK Ltd
-Guerbet Lab
-Leib Medical
-Uniphar MedTech

Buying options

Direct Award or Further competition (all Lots)

Further useful information

An overview of the Contrast Media and Associated Injectors/Consumables framework was provided in a customer webinar that took place on 12 June 2025. If you were unable to attend, we are delighted to share the webinar recording and the presentation slides with members. Please note, you will need your NHS LPP member login to access the recording and slides web page.

Access agreement and contact details

For more information about this framework and further guidance documentation, please complete the short request access agreement form here or email Nilton Melo directly at nilton.melo1@nhs.net.